Business Description
HSBC Holdings plc functions as a prominent global entity, delivering a full spectrum of banking and financial services around the world. Its operations are structured into three key divisions: Wealth and Personal Banking, Commercial Banking, and Global Banking and Markets. The Wealth and Personal Banking unit is dedicated to individual customers, supplying a broad array of retail banking offerings. This includes essential services like current and savings accounts, various lending products such as mortgages and personal loans, a selection of credit and debit cards, and convenient local and international payment facilities. Furthermore, this segment provides in-depth wealth management solutions, encompassing insurance and investment products, worldwide asset management expertise, and tailored private wealth strategies for both general banking clients and affluent individuals. The Commercial Banking division targets businesses across the size spectrum. It extends crucial services such as credit and financing, treasury and cash flow management, payment processing, business insurance, and investment support. Additionally, it offers corporate cards, international trade and receivables financing, foreign exchange transactions, capital-raising capabilities via debt and equity markets, and strategic advisory services. Its client base spans from small and medium-sized enterprises to larger corporations. Lastly, the Global Banking and Markets segment focuses on advanced financial services for major organizations and investors. It provides sophisticated financing, expert advisory, and transaction execution across various asset classes, including credit, interest rates, foreign exchange, equities, and money market instruments, along with comprehensive securities services. This division also undertakes principal investment activities, serving governmental bodies, corporate entities, institutional clients, and high-net-worth private investors. Founded in 1865, HSBC Holdings plc maintains its central operations in London, United Kingdom.
Business History
Generated: Jun 26, 2026 3:02amPrice Overview
Last updated: Jun 26, 2026 3:00am (1d ago)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 6.05
Total Equity: $198.23B
Shares: 3,509,400,000
Total Debt: $256.14B
Cash: $307.74B
EBITDA: $29.03B
Total Debt: $256.14B
Cash: $307.74B
Revenue: $147.86B
Revenue: $147.86B
Revenue: $147.86B
Total Equity: $198.23B
Tax Rate: 25.1%
Equity: $198.23B
Total Debt: $256.14B
Cash: $307.74B
Current Liabilities: $1,987.43B
Long-Term Debt: $256.14B
Total Debt: $256.14B
Total Equity: $198.23B
Shares: 3,509,400,000
Shares: 3,509,400,000
CapEx: -$4.66B
Shares: 3,509,400,000
Stock Price: $95.06
Net Income: $22.34B
Industry Benchmarks
Advanced Analysis Forensic deep-dive · three lenses
HSBC is throwing off real cash: FCF of $25.1B in 2025 against $22.3B net income (OCF/NI 2.98x, accruals -1.1% of assets) and revenue has climbed from $74B in 2021 to $148B in 2025 as the rate cycle lifted net interest income. Operating margin sits around 20-26% across the window and net income has roughly doubled from $13.9B (2021) to $22-24B (2023-2025), a clean re-rating of underlying earnings power. Capital return is disciplined: diluted shares fell from 4.06B to 3.51B (-3.6% CAGR), SBC is a trivial 0.4% of revenue, and buyback spend is ~14x SBC, so per-share value is being concentrated rather than diluted.
Verify before trusting this (6)
- CET1 ratio, LCR, and NSFR trajectory across 2021-2025 to confirm regulatory capital strength
- Loan-loss provisioning and stage 3 / NPL ratios - is the cash flow strength masked by under-reserving?
- Geographic exposure mix, particularly Hong Kong / mainland China commercial real estate writedowns
- Whether the 2023 revenue jump reflects the sale of Canadian unit / Argentina divestiture or organic NII
- Dividend payout ratio and buyback authorization remaining versus distributable reserves
- Cost-to-income ratio trend explaining the OpM compression from 25.6% to 20.3%
The e2e composite fair value sits at $137.51 with a signal-adjusted $143.01, implying ~45-50% upside. I haircut that: the EPV-floor of $174 looks runaway for a bank facing NIM compression and rate-cut headwinds, while the anchored-PE of $100.64 is the most credible peer-anchored read. Splitting the difference and giving credit for the Strong quality grade (buybacks shrinking the float, fat cash conversion, Asia franchise), a defensible deserved value lands in the $115-135 band. Against $95.06, that is a 20-30% gap - meaningful, not heroic.
Verify before trusting this (5)
- NIM guidance and sensitivity to rate cuts in next results
- Pace and authorization size of remaining buyback program
- CET1 ratio trajectory and any capital return constraints
- China/HK commercial real estate exposure and provisioning
- Asia wealth fee growth trend
HSBC is a low-beta (0.58) diversified global bank in a neutral macro tape (VIX 18.9, S&P -3.3% off highs). The market regime barely touches this name - defensive, dividend-paying, Asia-exposed banks are exactly the kind of cohort that absorbs a wobbly tape without getting marked down. The narrative archetype is 'fallen-angel' with minimal intensity, meaning there is no euphoric story to deflate and no hostile narrative actively de-rating it either. That is itself a quiet tailwind: the stock has rallied 73% over the year on improving fundamentals rather than story-stock froth, so it is not vulnerable to a narrative crack. News flow is constructive - portfolio cleanup (Singapore insurance sale to Allianz, Indonesia wealth exit to OCBC), an AI integration with Google, and continued dividend credibility (27 straight years). These are 'boring good' headlines that reinforce the fortress-balance-sheet read. The one genuine divergence is analyst tone: consensus Hold with a $52 target versus a $95 price and zero recent revisions. That is a stale, backward-looking book that has not caught up to the re-rating - historically this kind of lagging downgrade gap creates upward revision pressure rather than selling pressure, because the analyst community will be forced to chase. Net: modest but real positive pressure, capped by the lack of any cult or momentum-chasing crowd.
Verify before trusting this (4)
- Whether sell-side targets get revised up off the stale $52 - first upgrade is the catalyst
- Any crack in the Asia/HK growth story or HK property/credit headlines that would reignite the bear narrative
- VIX above 25 or a credit-spread widening event that would finally bite even low-beta banks
- Pace of portfolio simplification - more disposal headlines reinforce the tailwind
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 26, 2026 3:05am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $73.9B | $76.2B | $129.5B | $143.3B | $147.9B |
| Cost of Revenue | $9.7B | $22.4B | $65.1B | $75.9B | $67.1B |
| Gross Profit | $64.2B | $53.7B | $64.4B | $67.4B | $80.8B |
| Operating Expenses | $45.3B | $36.7B | $34.1B | $35.1B | $50.8B |
| Operating Income | $18.9B | $17.1B | $30.3B | $32.3B | $30.0B |
| Net Income | $13.9B | $15.6B | $23.5B | $24.0B | $22.3B |
| EBITDA | $23.2B | $20.9B | $33.8B | $36.4B | $29.0B |
| EPS | $3.10 | $3.60 | $5.75 | $6.25 | $6.05 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 26, 2026 3:00am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $422.4B | $350.1B | $299.6B | $284.5B | $307.7B |
| Total Current Assets | $422.4B | $350.1B | $319.8B | $298.3B | $652.0B |
| Total Assets | $3.0T | $3.0T | $3.0T | $3.0T | $3.2T |
| Current Liabilities | $10.5B | $12.4B | $1.8T | $1.8T | $2.0T |
| Long-Term Debt | $225.7B | $204.2B | $235.2B | $242.3B | $256.1B |
| Total Liabilities | $2.8T | $2.8T | $2.8T | $2.8T | $3.0T |
| Total Equity | $198.3B | $177.8B | $185.3B | $185.0B | $198.2B |
| Retained Earnings | $144.5B | $142.4B | $152.1B | $152.4B | $169.6B |
Cash Flow (Annual)
Last updated: Jun 26, 2026 3:05am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $104.3B | $26.4B | $39.1B | $65.3B | $29.8B |
| Capital Expenditure | -$3.6B | -$4.4B | -$3.7B | -$3.9B | -$4.7B |
| Free Cash Flow | $100.7B | $22.0B | $35.4B | $61.4B | $25.1B |
| Acquisitions (net) | -$106.0M | -$989.0M | -$453.0M | -$2.7B | -$325.0M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$2.1B | -$2.4B | -$6.4B | -$11.9B | -$12.7B |
| Net Change in Cash | $105.7B | -$52.4B | -$30.7B | -$56.0B | -$2.1B |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 3:00am (1d ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$77.3B $76.9B – $77.6B
|
$81.3B $80.0B – $82.1B
|
$84.5B $83.2B – $85.3B
|
$87.7B $86.3B – $88.5B
|
| EBITDA |
$20.1B $20.0B – $20.2B
|
$21.1B $20.8B – $21.3B
|
$22.0B $21.6B – $22.2B
|
$22.8B $22.4B – $23.0B
|
| Net Income |
$32.6B $31.6B – $34.1B
|
$35.6B $34.9B – $36.0B
|
$38.6B $37.8B – $39.1B
|
$44.7B $43.9B – $45.3B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 26, 2026 3:05am (1d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +3.0% | +70.0% | +10.6% | +3.2% |
| Gross Profit Growth | -16.4% | +20.0% | +4.6% | +19.9% |
| Operating Income Growth | -9.8% | +77.9% | +6.5% | -7.2% |
| Net Income Growth | +11.8% | +51.3% | +1.9% | -6.8% |
| EBITDA Growth | -9.8% | +61.7% | +7.6% | -20.2% |
Insider Trading (Recent)
Last updated: Jun 26, 2026 3:04am (1d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-22 | Palomaki Daniel Scott | A-Award | 88.00 | $0.00 | $0 |
| 2026-05-07 | Palomaki Daniel Scott | S-Sale | 23,123.00 | $18.11 | $418,667 |
| 2026-04-01 | Palomaki Daniel Scott | 0.00 | $0.00 | $0 | |
| 2026-04-01 | Palomaki Daniel Scott | 15,241.00 | $0.00 | $0 | |
| 2026-04-01 | Palomaki Daniel Scott | 428.00 | $0.00 | $0 | |
| 2026-03-27 | Bingham Jonathan | P-Purchase | 13.00 | $15.81 | $205 |
| 2026-03-20 | Bingham Jonathan | A-Award | 792.00 | $0.00 | $0 |
| 2026-03-17 | Bingham Jonathan | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Bingham Jonathan | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Bingham Jonathan | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Bingham Jonathan | 28,081.00 | $0.00 | $0 |
Dividend History (Last 20)
Last updated: Jun 26, 2026 3:00am (1d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-05-15 | $0.50 | 2026-05-05 | 2026-05-15 | 2026-06-26 |
| 2026-03-13 | $2.25 | 2026-02-25 | 2026-03-13 | 2026-04-30 |
| 2025-11-07 | $0.50 | 2025-10-28 | 2025-11-07 | 2025-12-18 |
| 2025-08-15 | $0.50 | 2025-07-30 | 2025-08-15 | 2025-09-26 |
| 2025-05-09 | $0.50 | 2025-04-29 | 2025-05-09 | 2025-06-20 |
| 2025-03-07 | $1.80 | 2025-02-19 | 2025-03-07 | 2025-04-25 |
| 2024-11-08 | $0.50 | 2024-10-29 | 2024-11-08 | 2024-12-19 |
| 2024-08-16 | $0.50 | 2024-07-31 | 2024-08-16 | 2024-09-27 |
| 2024-05-09 | $1.55 | 2024-05-01 | 2024-05-10 | 2024-06-21 |
| 2024-03-07 | $1.55 | 2024-02-22 | 2024-03-08 | 2024-04-25 |
| 2023-11-09 | $0.50 | 2023-10-30 | 2023-11-10 | 2023-12-21 |
| 2023-08-10 | $0.50 | 2023-08-01 | 2023-08-11 | 2023-09-21 |
| 2023-05-11 | $0.50 | 2023-05-02 | 2023-05-12 | 2023-06-23 |
| 2023-03-02 | $1.15 | 2023-02-21 | 2023-03-03 | 2023-04-27 |
| 2022-08-18 | $0.45 | 2022-08-01 | 2022-08-19 | 2022-09-29 |
| 2022-03-10 | $0.90 | 2022-02-24 | 2022-03-11 | 2022-04-28 |
| 2021-08-19 | $0.35 | 2021-08-03 | 2021-08-20 | 2021-09-30 |
| 2021-03-11 | $0.75 | 2021-02-23 | 2021-03-12 | 2021-04-29 |
| 2020-02-27 | $1.05 | 2020-02-19 | 2020-02-28 | 2020-04-14 |
| 2019-10-10 | $0.50 | 1900-01-01 | 2019-10-11 | 2019-11-20 |
Narrative Economics
market-narrative step).
Delvantic AI Findings
The raw numbers tell a less exciting story than the synthesis verdict implies. Annual revenue of $147.86B in 2025 vs $143.29B in 2024 is +3.2% growth, and net income actually *declined* from $23.98B to $22.34B — that's the opposite of "accelerating." The 6.9% revenue CAGR is flattered by the 2022→2023 jump (rates regime change: $76B to $129B), which is a one-time rate-cycle benefit, not a growth trajectory. Strip that out and HSBC is a flat-to-declining earnings franchise with a 4.2% dividend yield. ROE of 12% and ROA of 0.69% are pedestrian for a global bank — JPM runs 17%+ ROE. The quarterly print pattern (Q1 ~$7.3B NI, other quarters $4.7-5.3B) screams seasonality/one-offs, not a clean run-rate.
The synthesis's $137-143 fair value (+50% upside) deserves real skepticism. A DCF on a global bank with declining earnings, 12% ROE, and structural Asia/UK regulatory drag should not produce that gap unless you're assuming mean-reversion to a higher ROTE that management has been promising for a decade and not delivering. P/B of 1.54 is *not* cheap for a bank earning 12% ROE — that's roughly fair. The narrative layer correctly flags this: P/B of 0.6-0.8x was the old setup; at 1.54x P/B the "deep discount" thesis is largely played out. Someone is double-counting — the pre-flight thesis assumes 0.6-0.8x P/B, but the canonical metric says 1.54x. HSBC has already re-rated meaningfully (stock at $95 vs. sub-$40 in 2020). The "fallen angel at a discount" frame is stale.
A careful contrarian would argue: (1) HSBC's earnings are at peak NIM — as global rates normalize lower, that $22-24B NI compresses back toward $16-18B, making the current 14.6x P/E look like 18-20x on normalized earnings; (2) the Hong Kong/China commercial real estate exposure remains an unquantified tail, and the 1% margin print in Q4 2024 ($351M NI on $34.6B revenue) is a reminder that big writedowns happen with no warning; (3) buybacks have done the heavy lifting on EPS — without continued capital return at this pace, the dividend-income thesis weakens; (4) the insider sale of 23,123 shares in May 2026 with only token purchases is mildly negative, not "neutral." The market-forces "neutral" call and the narrative engine's "fundamentals-anchored, minimal narrative intensity" read are both more honest than the synthesis's +50% upside claim.
I dissent from the synthesis. Fair value is closer to $100-110, not $137-143 — that's 5-15% upside plus the 4.2% yield, which is a respectable total-return setup for a dividend-income name but not a screaming buy. The TTM-derived metrics (P/E 14.6, ROE 12%, EV/EBITDA 16.9) are reasonable but not anomalously cheap; the anomaly flags are technically correct but don't change the conclusion. The pre-flight's premise that this trades at "0.6-0.8x P/B" is factually wrong given the 1.54x canonical figure — that error inflates the entire undervaluation thesis downstream. What would change my mind: a clean Q2/Q3 2026 print showing the $7.3B Q1 NI is repeatable (implying $25B+ annualized), or evidence the Asia wealth franchise is compounding fee income at double digits. Until then, this is a hold-for-yield, not an aggressive buy.
GPT Critique
In my own reading of HSBC's raw data, I see a mixed picture with some noteworthy points. The company's recent quarterly revenue is relatively stable, hovering around $33 billion, though the net income shows significant fluctuations. For instance, Q1 2026 saw a net income of $7.35 billion, a stark contrast to the $4.73 billion in Q2 2025. This indicates some seasonality or one-off effects, as Opus suggested. On an annual basis, HSBC's revenue growth from $129.51 billion in 2023 to $147.86 billion in 2025 reflects a modest CAGR of 6.9%. However, the declining net income from $23.98 billion in 2024 to $22.34 billion in 2025 suggests underlying margin pressures. The current P/E ratio of 14.6 and P/B of 1.54 imply that HSBC is trading at a fair valuation compared to its financial peer group, especially considering its ROE of 12%, which is below some global competitors like JPMorgan.
I agree with Opus's skepticism regarding the synthesis's valuation of HSBC. Opus rightly points out that the +50% upside potential from the synthesis is overly optimistic, especially given the company's flat-to-declining earnings profile. The assertion that HSBC's re-rating has already occurred is supported by the current P/B ratio of 1.54, which is not reflective of a deeply discounted stock. I concur with Opus that assuming a fair value of $100-110 is more plausible, recognizing the modest 5-15% upside plus the dividend yield. This is more aligned with the actual market sentiment and HSBC's financial performance trajectory.
However, I diverge from Opus on the impact of insider transactions. Opus notes the insider sale of 23,123 shares as mildly negative, whereas I would consider this within the context of typical trading patterns; one transaction is insufficient to imply a broader trend without additional context. Additionally, while Opus attributes the narrative engine's minimal intensity to a grounded fundamentals story, I would argue that the geopolitical risks and strategic identity issues might have a more pronounced impact on investor sentiment than Opus credits.
A careful skeptic might argue that both Opus and I are underestimating the potential impact of HSBC's strategic "pivot to Asia." If HSBC can effectively leverage its position in Asia-Pacific markets, particularly if China and other emerging markets stabilize economically, this could drive substantial future growth not currently reflected in the valuation. Additionally, the skeptic would point to the massive cash reserves of $307.74 billion as a buffer against potential geopolitical and market volatility, which could be used strategically to enhance shareholder value beyond current expectations.